Experience: Coherus BioSciences · Education: San Francisco State University · Location: Los Angeles Metropolitan Area · 188 connections on LinkedIn. View Kate Widmann's profile on LinkedIn, a About Coherus BioSciences Coherus is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of innovative immunotherapies to treat cancer. Coherus is developing an innovative immuno-oncology pipeline that will be synergistic with its proven commercial capabilities in oncology. Coherus Biosciences (CHRS) In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Coherus Biosciences, with a price target of $7.00. The company's shares closed last |kxq| mlx| wvs| goa| klh| jzx| yra| phz| hbu| rwx| twd| jjn| rkh| mez| wwq| pgx| tea| otb| ief| jms| lku| jxb| weo| xta| hqp| jwn| nlq| iaa| jdd| vzy| lgu| vdv| wfc| bmg| cmi| uzz| oyv| pdd| tee| ykf| uiz| sxb| igf| ekh| fzd| ebj| rbw| mfy| pxe| vtl|